Literature DB >> 11004291

Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

S D Pendergast1, T S Hassan, G A Williams, M S Cox, R R Margherio, P J Ferrone, B R Garretson, M T Trese.   

Abstract

PURPOSE: To evaluate the role of vitrectomy in eyes with diffuse diabetic macular edema associated with a taut posterior hyaloid.
METHODS: Records of 55 eyes of 50 patients with diabetic retinopathy and diffuse clinically significant diabetic macular edema who underwent vitrectomy with stripping of the premacular posterior hyaloid were reviewed. In all 55 eyes, diffuse diabetic macular edema was present on contact lens examination and confirmed with fluorescein angiography. On fundus examination, the premacular posterior hyaloid was attached and appeared taut.
RESULTS: The mean preoperative best-corrected visual acuity was 20/160, and the mean final best-corrected visual acuity was 20/80 (P <.0001, Wilcoxon signed rank test), with 27 (49.1%) of the 55 eyes demonstrating improvement in best-corrected visual acuity of 2 or more lines. Fifty-two (94.5%) of the 55 vitrectomized eyes showed improvement in clinically significant macular edema and in 45 eyes (81.8%) the macular edema resolved completely during a mean period of 4.5 months (range, 1 to 13 months). Eyes with macular ischemia and preoperative best-corrected visual acuity of 20/200 or less tended to respond less favorably to vitrectomy than eyes lacking these characteristics. All eyes had at least 6 months of follow-up after surgery, with a mean follow-up of 23.2 months.
CONCLUSION: In eyes with persistent diffuse diabetic macular edema with a taut premacular posterior hyaloid face unresponsive to laser therapy, vitrectomy with removal of the posterior hyaloid appears to be beneficial in some cases. Careful selection of eyes with favorable preoperative clinical characteristics may improve surgical outcomes.

Entities:  

Mesh:

Year:  2000        PMID: 11004291     DOI: 10.1016/s0002-9394(00)00472-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  61 in total

1.  The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema.

Authors:  Anjali S Maheshwary; Stephen F Oster; Ritchie M S Yuson; Lingyun Cheng; Francesca Mojana; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-05-10       Impact factor: 5.258

Review 2.  Surgical treatment of diabetic retinopathy.

Authors:  Horst Helbig; Florian K P Sutter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

3.  Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Authors:  Brett J Rosenblatt; Gaurav K Shah; Sanjay Sharma; Jeff Bakal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-31       Impact factor: 3.117

Review 4.  [Surgery for macular edema].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

5.  Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.

Authors:  Atul Kumar; Subijay Sinha; Rajvardhan Azad; Yog Raj Sharma; Rajpal Vohra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-09       Impact factor: 3.117

6.  Perifoveal vitreous detachment and its macular complications.

Authors:  Mark W Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2005

7.  Cystoid puncture for chronic cystoid macular oedema.

Authors:  Rishi P Singh; Ronald Margolis; Peter K Kaiser
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

8.  A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.

Authors:  D Thomas; C Bunce; C Moorman; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

9.  A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.

Authors:  Ingrid U Scott; Allison R Edwards; Roy W Beck; Neil M Bressler; Clement K Chan; Michael J Elman; Scott M Friedman; Craig Michael Greven; Raj K Maturi; Dante J Pieramici; Michel Shami; Lawrence J Singerman; Cynthia R Stockdale
Journal:  Ophthalmology       Date:  2007-08-15       Impact factor: 12.079

10.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

Authors: 
Journal:  Ophthalmology       Date:  2008-07-26       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.